The neutrophil membrane acts as a high-capacity biological sponge, binding and neutralizing pro-inflammatory cytokines like TNF-α and IL-6, thereby dampening systemic or localized inflammatory responses.
Neutrophil Membrane Coated Nanoparticle for Targeted Drug Delivery
Neutrophil membrane-coated nanoparticles (NM-NPs) are the next generation of nanomedicine, offering superior drug delivery precision. Creative Biolabs provides specialized development services for NM-NP systems, solving key client challenges like immune evasion and poor targeting efficiency inherent in traditional PEGylated carriers, thus accelerating clinical translation.
Click Here to View more about our Service
Introduction to Neutrophil Membrane Coated Nanoparticles
NM-NPs are biomimetic nanocarriers created by cloaking synthetic cores (such as PLGA or inorganic NPs) with natural neutrophil cell membranes. Neutrophils are the body's most abundant white blood cells. This innovative structure is achieved through a proprietary platform, which utilizes compliant protocols for high-integrity membrane isolation and precise extrusion techniques for stable coating. The resulting NM-NP effectively transfers the biological functionality of the cell—its immune evasion and migratory capability—to the synthetic drug carrier, overcoming the limitations of first-generation stealth technologies like PEGylation.
Advantages of Neutrophil Membrane Coated Nanoparticles
NM-NPs offer superior performance through their retained dual functionality, leveraging natural membrane proteins:
Immune Evasion (Stealth)
The membrane retains the CD47 protein, which acts as a "Don't Eat Me" signal by engaging the SIRPα receptor on macrophages. This recognition as "self" dramatically prolongs the nanoparticle's circulation time in the bloodstream and minimizes non-specific clearance by the Reticuloendothelial System (RES).
Active Targeting (Homing)
The natural membrane preserves essential chemokine receptors (such as CD11b). This grants the NM-NP an innate, active tropism toward inflammatory and injury signals.
Enhanced Accumulation
By exploiting this biological mechanism, NM-NPs can actively migrate to the disease locus, achieving proven accumulation up to 3.5-fold higher in inflamed tissue or tumor vasculature compared to passive, conventional nanoparticles.
Applications of Neutrophil Membrane Coated Nanoparticles
Chronic Inflammation and Autoimmunity
Targeted Gene Silencing
NM-NPs loaded with Antisense Oligonucleotides (ASOs) or other nucleic acids can exploit specific protein interactions (e.g., CD18/ICAM-1) to actively target inflamed endothelial cells and achieve precise gene regulation, as demonstrated in preclinical atherosclerosis models.
Oncology and Metastasis Prevention
NM-NPs leverage the natural homing ability of neutrophils to infiltrate the tumor microenvironment or the pre-metastatic niche. They can deliver potent cytotoxic agents to neutralize circulating tumor cells (CTCs) in the bloodstream, disrupting the early, critical stages of cancer spread (metastasis).
Targeted Anti-Infective Therapy
Their inflammatory homing ability concentrates antibiotic payloads precisely at sites of severe, deep-seated infection (e.g., pneumonia or sepsis), ensuring localized efficacy while drastically reducing systemic exposure and the risk of off-target effects and antibiotic resistance.
Table.1 Examples of NM-NPs applications.
| Application Area | NP Core | Key Mechanism |
|---|---|---|
| Chronic Inflammation | PLGA/Liposomes | Cytokine Decoy (TNF-α, IL-6 binding) |
| Atherosclerosis | Metal-Organic Framework (ZIF-8) | Active Homing (CD18 to ICAM-1) for Gene Silencing (Anti-miR-155) |
| Oncology/Metastasis | Inorganic NPs | Chemotactic Homing to Pre-metastatic Niche |
Fig.1 In vitro synthesis and in vivo therapeutic mechanisms of the peptide-anchored neutrophil membrane-coated biomimetic nanoparticles.1
Related Services
Creative Biolabs specializes in developing custom NM-NP delivery systems, compatible with various core types (PLGA, liposomes, inorganic NPs) via our advanced platform. We offer development support and rigorous quality assurance for biomimetic drug delivery systems. Contact us today to discuss your advanced nanomedicine needs.
Reference
- Yang, Ni, et al. "Peptide-anchored neutrophil membrane-coated biomimetic nanodrug for targeted treatment of rheumatoid arthritis." Journal of Nanobiotechnology 21.1 (2023): 13. Distributed under Open Access license CC BY 4.0, without modification. https://doi.org/10.1186/s12951-023-01773-x
Our services are For Research Use Only. We do not provide services to individuals.
Online Inquiry
